423 related articles for article (PubMed ID: 16835222)
1. CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1.
Isenberg JS; Ridnour LA; Dimitry J; Frazier WA; Wink DA; Roberts DD
J Biol Chem; 2006 Sep; 281(36):26069-80. PubMed ID: 16835222
[TBL] [Abstract][Full Text] [Related]
2. Thrombospondin-1 inhibits nitric oxide signaling via CD36 by inhibiting myristic acid uptake.
Isenberg JS; Jia Y; Fukuyama J; Switzer CH; Wink DA; Roberts DD
J Biol Chem; 2007 May; 282(21):15404-15. PubMed ID: 17416590
[TBL] [Abstract][Full Text] [Related]
3. Thrombospondin-1 antagonizes nitric oxide-stimulated vascular smooth muscle cell responses.
Isenberg JS; Wink DA; Roberts DD
Cardiovasc Res; 2006 Sep; 71(4):785-93. PubMed ID: 16820142
[TBL] [Abstract][Full Text] [Related]
4. Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide/cGMP signaling.
Isenberg JS; Romeo MJ; Yu C; Yu CK; Nghiem K; Monsale J; Rick ME; Wink DA; Frazier WA; Roberts DD
Blood; 2008 Jan; 111(2):613-23. PubMed ID: 17890448
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of ABT-510 and a CD36-binding peptide derived from the type 1 repeats of thrombospondin-1 on fatty acid uptake, nitric oxide signaling, and caspase activation in vascular cells.
Isenberg JS; Yu C; Roberts DD
Biochem Pharmacol; 2008 Feb; 75(4):875-82. PubMed ID: 18068687
[TBL] [Abstract][Full Text] [Related]
6. Thrombospondin-1 inhibition of vascular smooth muscle cell responses occurs via modulation of both cAMP and cGMP.
Yao M; Roberts DD; Isenberg JS
Pharmacol Res; 2011 Jan; 63(1):13-22. PubMed ID: 20971192
[TBL] [Abstract][Full Text] [Related]
7. Differential interactions of thrombospondin-1, -2, and -4 with CD47 and effects on cGMP signaling and ischemic injury responses.
Isenberg JS; Annis DS; Pendrak ML; Ptaszynska M; Frazier WA; Mosher DF; Roberts DD
J Biol Chem; 2009 Jan; 284(2):1116-25. PubMed ID: 19004835
[TBL] [Abstract][Full Text] [Related]
8. Thrombospondin-1 inhibits VEGF receptor-2 signaling by disrupting its association with CD47.
Kaur S; Martin-Manso G; Pendrak ML; Garfield SH; Isenberg JS; Roberts DD
J Biol Chem; 2010 Dec; 285(50):38923-32. PubMed ID: 20923780
[TBL] [Abstract][Full Text] [Related]
9. Enhancing cardiovascular dynamics by inhibition of thrombospondin-1/CD47 signaling.
Isenberg JS; Frazier WA; Krishna MC; Wink DA; Roberts DD
Curr Drug Targets; 2008 Oct; 9(10):833-41. PubMed ID: 18855617
[TBL] [Abstract][Full Text] [Related]
10. Thrombospondin-1 and CD47 regulate blood pressure and cardiac responses to vasoactive stress.
Isenberg JS; Qin Y; Maxhimer JB; Sipes JM; Despres D; Schnermann J; Frazier WA; Roberts DD
Matrix Biol; 2009 Mar; 28(2):110-9. PubMed ID: 19284971
[TBL] [Abstract][Full Text] [Related]
11. Amyloid-β inhibits No-cGMP signaling in a CD36- and CD47-dependent manner.
Miller TW; Isenberg JS; Shih HB; Wang Y; Roberts DD
PLoS One; 2010 Dec; 5(12):e15686. PubMed ID: 21203512
[TBL] [Abstract][Full Text] [Related]
12. Thrombospondin-1-CD47 blockade and exogenous nitrite enhance ischemic tissue survival, blood flow and angiogenesis via coupled NO-cGMP pathway activation.
Isenberg JS; Shiva S; Gladwin M
Nitric Oxide; 2009 Aug; 21(1):52-62. PubMed ID: 19481167
[TBL] [Abstract][Full Text] [Related]
13. The contribution of cross-talk between the cell-surface proteins CD36 and CD47-TSP-1 in osteoclast formation and function.
Koduru SV; Sun BH; Walker JM; Zhu M; Simpson C; Dhodapkar M; Insogna KL
J Biol Chem; 2018 Sep; 293(39):15055-15069. PubMed ID: 30082316
[TBL] [Abstract][Full Text] [Related]
14. Thrombospondin-1 inhibits endothelial cell responses to nitric oxide in a cGMP-dependent manner.
Isenberg JS; Ridnour LA; Perruccio EM; Espey MG; Wink DA; Roberts DD
Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13141-6. PubMed ID: 16150726
[TBL] [Abstract][Full Text] [Related]
15. Thrombospondin-1 is a CD47-dependent endogenous inhibitor of hydrogen sulfide signaling in T cell activation.
Miller TW; Kaur S; Ivins-O'Keefe K; Roberts DD
Matrix Biol; 2013 Aug; 32(6):316-24. PubMed ID: 23499828
[TBL] [Abstract][Full Text] [Related]
16. Thrombospondin-1 differentially induces chemotaxis and DNA synthesis of human venous smooth muscle cells at the receptor-binding level.
Lymn JS; Patel MK; Clunn GF; Rao SJ; Gallagher KL; Hughes AD
J Cell Sci; 2002 Nov; 115(Pt 22):4353-60. PubMed ID: 12376566
[TBL] [Abstract][Full Text] [Related]
17. Thrombospondin-1 signaling through CD47 inhibits cell cycle progression and induces senescence in endothelial cells.
Gao Q; Chen K; Gao L; Zheng Y; Yang YG
Cell Death Dis; 2016 Sep; 7(9):e2368. PubMed ID: 27607583
[TBL] [Abstract][Full Text] [Related]
18. Thrombospondin-1 and CD47 limit cell and tissue survival of radiation injury.
Isenberg JS; Maxhimer JB; Hyodo F; Pendrak ML; Ridnour LA; DeGraff WG; Tsokos M; Wink DA; Roberts DD
Am J Pathol; 2008 Oct; 173(4):1100-12. PubMed ID: 18787106
[TBL] [Abstract][Full Text] [Related]
19. Involvement of a CD47-dependent pathway in platelet adhesion on inflamed vascular endothelium under flow.
Lagadec P; Dejoux O; Ticchioni M; Cottrez F; Johansen M; Brown EJ; Bernard A
Blood; 2003 Jun; 101(12):4836-43. PubMed ID: 12609828
[TBL] [Abstract][Full Text] [Related]
20. Thrombospondin-1 and CD47 regulation of cardiac, pulmonary and vascular responses in health and disease.
Rogers NM; Sharifi-Sanjani M; Csányi G; Pagano PJ; Isenberg JS
Matrix Biol; 2014 Jul; 37():92-101. PubMed ID: 24418252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
